Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis

被引：24

作者：

Pardanani, A. ^{[1
,2
]}

Chen, D. ^{[3
]}

Abdelrahman, R. A. ^{[1
,2
]}

Reichard, K. K. ^{[3
]}

Zblewski, D. ^{[1
,2
]}

Wood, A. J. ^{[3
]}

McClure, R. F. ^{[3
]}

Butterfield, J. H. ^{[4
]}

Hanson, C. A. ^{[3
]}

Tefferi, A. ^{[1
,2
]}

机构：

[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA

[2] Mayo Clin, Dept Med, Rochester, MN USA

[3] Mayo Clin, Dept Lab Med & Pathol, Div Hematopathol, Rochester, MN USA

[4] Mayo Clin, Dept Med, Div Allergy, Rochester, MN USA

来源：

LEUKEMIA | 2013年 / 27卷 / 10期

关键词：

SYSTEMIC MASTOCYTOSIS; CLASSIFICATION; DISORDERS; MUTATIONS; TET2;

D O I：

10.1038/leu.2013.227

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2091 / 2094

页数：5

共 15 条

[1] Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis [J].

Akin, Cem ;

Scott, Linda M. ;

Kocabas, Can N. ;

Kushnir-Sukhov, Nataliya ;

Brittain, Erica ;

Noel, Pierre ;

Metcalfe, Dean D. .

BLOOD, 2007, 110 (07) :2331-2333

[2] Mast cell activation syndrome: Proposed diagnostic criteria [J].

Akin, Cem ;

Valent, Peter ;

Metcalfe, Dean D. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (06) :1099-U60

[3] Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms [J].

Alvarez-Twose, Ivan ;

Gonzalez de Olano, David ;

Sanchez-Munoz, Laura ;

Matito, Almudena ;

Esteban-Lopez, Maria I. ;

Vega, Arantza ;

Belen Mateo, Maria ;

Alonso Diaz de Durana, Maria D. ;

de la Hoz, Belen ;

del Pozo Gil, Maria D. ;

Caballero, Teresa ;

Rosado, Ana ;

Sanchez Matas, Isabel ;

Teodosio, Cristina ;

Jara-Acevedo, Maria ;

Mollejo, Manuela ;

Garcia-Montero, Andres ;

Orfao, Alberto ;

Escribano, Luis .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (06) :1269-1278

[4] Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels [J].

Bonadonna, Patrizia ;

Perbellini, Omar ;

Passalacqua, Giovanni ;

Caruso, Beatrice ;

Colarossi, Sabrina ;

Dal Fior, Daniela ;

Castellani, Luca ;

Bonetto, Chiara ;

Frattini, Francesco ;

Dama, Annarita ;

Martinelli, Giovanni ;

Chilosi, Marco ;

Senna, Gianenrico ;

Pizzolo, Giovanni ;

Zanotti, Roberta .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) :680-686

[5] Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis [J].

Elliott, MA ;

Pardanani, A ;

Li, CY ;

Tefferi, A .

LEUKEMIA, 2004, 18 (05) :1027-1029

[6]

Horny HP, 2008, WHO CLASSIFICATION T, P54

[7] Inhibition of JAK-STAT signaling by TG101348: a novel mechanism for inhibition of KITD816V-dependent growth in mast cell leukemia cells [J].

Lasho, T. ;

Tefferi, A. ;

Pardanani, A. .

LEUKEMIA, 2010, 24 (07) :1378-1380

[8] Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors [J].

Lim, Ken-Hong ;

Tefferi, Ayalew ;

Lasho, Terra L. ;

Finke, Christy ;

Patnaik, Mrinal ;

Butterfield, Joseph H. ;

McClure, Rebecca F. ;

Li, Chin-Yang ;

Pardanani, Animesh .

BLOOD, 2009, 113 (23) :5727-5736

[9] Increased circulating IL-2Rα (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype study [J].

Pardanani, A. ;

Finke, C. ;

Abdelrahman, R. A. ;

Lasho, T. L. ;

Hanson, C. A. ;

Tefferi, A. .

LEUKEMIA, 2013, 27 (06) :1430-1433

[10] How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage) [J].

Pardanani, Animesh .

BLOOD, 2013, 121 (16) :3085-3094

← 1 2 →